Page last updated: 2024-12-05

succinonitrile

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Succinonitrile is a colorless, crystalline solid with a melting point of 57 °C. It is a dicyanide compound with the molecular formula C4H4N2. Succinonitrile is a versatile chemical intermediate used in the synthesis of various organic compounds, including polymers, pharmaceuticals, and pesticides. It is also a potential precursor to carbon nanomaterials. Succinonitrile is synthesized by the reaction of succinic acid with ammonia. The reaction is typically carried out in the presence of a catalyst, such as alumina or silica.'

succinonitrile: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8062
CHEMBL ID1562258
MeSH IDM0055747

Synonyms (67)

Synonym
EN300-35675
succinic acid nitrile
succinodinitrile
s-dicyanoethane
ethylene dicyanide
deprelin
succinil
ethane,2-dicyano-
usaf a-9442
dician
nsc4852
1,4-butanedinitrile
evanex
ethylene cyanide
disuxyl
nsc-4852
1,2-dicyanoethane
wln: nc2cn
dinile
butanedinitrile
succinic dinitrile
suxil
succinonitrile
succinic acid dinitrile
110-61-2
inchi=1/c4h4n2/c5-3-1-2-4-6/h1-2h
NCGC00091567-01
einecs 203-783-9
ccris 4720
sukcinonitril [czech]
ai3-06591
nsc 4852
brn 1098380
hsdb 7190
ethane, 1,2-dicyano-
succinonitrile, 99%
smr001224533
MLS002152938
FT-0654273
S0109
NCGC00091567-02
AKOS005721200
NCGC00258189-01
dtxcid706059
tox21_200635
cas-110-61-2
dtxsid9026059 ,
BBL011331
STL146417
unii-1r479o92do
ec 203-783-9
1r479o92do ,
sukcinonitril
succinonitrile [hsdb]
succinonitrile [mi]
succinonitrile [who-dd]
CHEMBL1562258
Q-201749
sym-dicyanoethane
ncch2ch2cn
F0001-0221
mfcd00001949
1,2-dicyano-ethan
succinonitrile, purum, >=97.0% (gc)
Q3502773
AMY25947
E78950

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency79.43280.004023.8416100.0000AID485290
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency28.18380.011212.4002100.0000AID1030
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency46.87710.003041.611522,387.1992AID1159552; AID1159553
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency50.11870.001019.414170.9645AID588537
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency26.69630.000323.4451159.6830AID743065
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency0.14130.00798.23321,122.0200AID2551
Nuclear receptor ROR-gammaHomo sapiens (human)Potency47.30790.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (52.78)18.7374
1990's1 (2.78)18.2507
2000's9 (25.00)29.6817
2010's4 (11.11)24.3611
2020's3 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.00 (24.57)
Research Supply Index3.76 (2.92)
Research Growth Index5.28 (4.65)
Search Engine Demand Index61.96 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other42 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]